Thanks. I had not noticed that. It was an accurate summary, imho, with the minor exception being that when they compared the info (indeterminate) group with the 331 blended trial data, they forgot to mention they were comparing it with the March 2017 data from the JTM -- not the improved data from SNO.
Nothing new, but anyone else notice they finally posted the June 4th press release on https://nwbio.com/press-releases/ ? I use a tool to track changes on web pages and got an alert, which is how I noticed.
I wonder what this website looked like between April 2015 and August 2015. Maybe you can use your tool to figure that out. I am particularly interested in the REC opinion of that moment.
IMO the "opinion" (or something like that) was: Reasons for delay correspond to:Sponsor
It looks like the UCLH paper states that the reasons for the "delay"(?) correspond to the "sponsor".
Thank you!
NOTE: I want to highlight this quote of Sentiment from the same day:
So if Germany put the brakes on, and Les mentions to diver that they don't want to have any other patients being treated unfairly (something like that)... that might add up to the company then deciding make the halt trial wide.
In my biased state, I personally believe the press release written for June 4, 2019 (but released and placed on the website today) was held in abeyance until the SAP was filed -- again, I think the SAP draft was filed with regulators on or before today.